by Clare Gerrard | Jul 10, 2023
Review of Carcinoid Syndrome: what is is and how it is treated by Joel George et al (Hampshire Hospitals and Kings Healthcare Partners ENETs Centre of Excellence) Online Publication Date: 19 Jun 2023 Neuroendocrine Cancers (aka neuroendocrine neoplasms or NENs) may... by Clare Gerrard | May 31, 2022
New ENETs Guidance paper for Carcinoid Syndrome & Carcinoid Heart Disease: Recommendations and Future Research Aims Carcinoid syndrome (CS) is the most frequent hormonal complication accompanying neuroendocrine neoplasms (NENs), predominantly encountered in up to... by Leanne Talbot | May 2, 2022
Carcinoid Heart Disease (CHD or Hedinger syndrome), is a rare condition that affects about one in five (20%) patients who have a Neuroendocrine Cancer AND Carcinoid Syndrome (CS). The precise cause is unknown but is thought to be related to abnormally raised levels of... by Leanne Talbot | Apr 23, 2021
April is Testicular Cancer Awareness month – Neuroendocrine Cancer of the Testes accounts for less than 1% of all testicular tumours. Diagnosis of Neuroendocrine Cancer of the Testes usually occurs following surgery or biopsy. Carcinoid Syndrome is a very rare... by Leanne Talbot | Apr 19, 2021
April is Bowel Cancer Awareness Month: Symptoms of Neuroendocrine Cancer of the Colon (Large Bowel) may be very similar to those that occur in Bowel Cancer, and include: A persistent change in your bowel habits, including diarrhoea or constipation or a change in the... 
